Smruthi Organics Ltd vs Vaishali Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Smruthi Organics Ltd is ₹ 116.05 as of 05 May 15:30 . The P/E Ratio of Smruthi Organics Ltd changed from 14.9 on March 2021 to 35.5 on March 2025 . This represents a CAGR of 18.96% over 5 yearsThe P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 years The Market Cap of Smruthi Organics Ltd changed from ₹ 254.45 crore on March 2021 to ₹ 126.2 crore on March 2025 . This represents a CAGR of -13.09% over 5 yearsThe Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 years The Revenue of Smruthi Organics Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 . The EBITDA of Smruthi Organics Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 . The Net Profit of Smruthi Organics Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 . The Dividend Payout of Smruthi Organics Ltd changed from 20.08 % on March 2021 to 48.24 % on March 2025 . This represents a CAGR of 19.16% over 5 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Smruthi Organics Ltd

Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995.
The Company was promoted by E Purushotham and Shankarrao R Myakal.
The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa.
It has 2 manufacturing facilities in Solapur, India. The Company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa).
It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin.

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

FAQs for the comparison of Smruthi Organics Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Smruthi Organics Ltd or Vaishali Pharma Ltd?

Market cap of Smruthi Organics Ltd is 132 Cr while Market cap of Vaishali Pharma Ltd is 100 Cr

What are the key factors driving the stock performance of Smruthi Organics Ltd and Vaishali Pharma Ltd?

The stock performance of Smruthi Organics Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Smruthi Organics Ltd and Vaishali Pharma Ltd?

As of May 5, 2026, the Smruthi Organics Ltd stock price is INR ₹116.05. On the other hand, Vaishali Pharma Ltd stock price is INR ₹7.73.

How do dividend payouts of Smruthi Organics Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Smruthi Organics Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.